全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

单核苷酸多态性与原发性肝癌易感性及临床病理学的相关分析
Correlation Analysis of Single Nucleotide Polymorphism with Susceptibility and Clinicopathology of Primary Hepatic Carcinoma

DOI: 10.12677/ACM.2023.134736, PP. 5193-5204

Keywords: 原发性肝癌,单核苷酸多态性,遗传易感性,临床病理学,聚合酶链反应–限制性片段长度多态性技术
Primary Hepatic Carcinoma
, Single Nucleotide Polymorphism, Genetic Susceptibility, Clinicopathology, PCR-RFLP

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:探讨单核苷酸多态性(SNP)与本地区原发性肝癌(PHC)遗传易感性的关系,并探究SNP位点数目与肝癌患者临床病理学的相关性。方法:采用聚合酶链反应–限制性片段长度多态性技术检测234例肝癌患者和234例阴性对照的27个PHC相关SNP位点基因型和等位基因分布频率,并分析SNP位点与PHC遗传易感性、肝癌患者临床病理学和SNP位点数目的相关性。结果:1) miR-34b/c基因rs4938723位点CC基因型(调整OR = 1.736,95%CI:1.036~2.910,P = 0.036)、EGF基因rs4444903位点GG基因型(调整OR = 1.841,95%CI:1.103~3.071,P = 0.019)具有更高的PHC患病风险;KIF1B基因rs17401966位点GG基因型具有更低的PHC患病风险(调整OR = 0.540,95%CI:0.314~0.930,P = 0.026);分层分析结果显示在男性(P = 0.039)和饮酒(P = 0.025)的人群中EGF基因rs4444903位点基因型GG相比AA + AG基因型PHC发病风险增加;在女性(P = 0.013)、年龄 < 60岁(P = 0.026)及不饮酒(P = 0.039)人群中KIF1B基因rs17401966位点GG基因型相比AA + AG基因型PHC发病风险降低。2) SNP位点数目与门静脉癌栓发生率增加有关(调整OR = 1.122,95%CI:1.005~1.251,P = 0.040)。结论:miR-34b/c基因rs4938723、EGF基因rs4444903、KIF1B基因rs17401966单核苷酸多态性与本地区PHC风险相关,SNP位点数目与肝癌患者临床病理学具有相关性。
Objective: To investigate the relationship between single nucleotide polymorphism (SNP) and ge-netic susceptibility to primary hepatic carcinoma (PHC) in local population, and to explore the cor-relation between the number of SNPs and clinicopathology in patients with PHC. Methods: Poly-merase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to detect the genotype and allele distribution frequency of 27 PHC-associated SNPs in 234 hepatocellular car-cinoma patients and 234 negative controls, and to analyze the correlation between SNPs and genet-ic susceptibility to PHC, clinicopathology of hepatocellular carcinoma patients and the number of SNPs. Results: 1) The miR-34b/c gene loci rs4938723 CC genotype (adjusted OR = 1.736, 95%CI; 1.036~2.910, P = 0.036) and EGF gene loci rs4444903 GG genotype (adjusted OR = 1.841, 95%CI; 1.103~3.071, P = 0.019) had a higher risk of PHC. The KIF1B gene loci rs17401966 GG genotype (adjusted OR = 0.540, 95%CI; 0.314~0.930, P = 0.026) had lower risk of PHC. The stratification analysis showed that EGF rs4444903 GG genotype had a higher risk than AA + AG genotype in male (P = 0.039), and alcoholic population (P = 0.025), KIF1B rs17401966 GG genotype had a lower risk than AA + AG genotype in female (P = 0.013), age < 60 years (P = 0.026) and non-alcoholic popula-tion (P = 0.039). 2) More SNPs resulted in higher incidence of portal vein carcinoma thrombosis (adjusted OR = 1.122, 95%CI; 1.005~1.251, P = 0.040). Conclusion: Single nucleotide polymor-phisms in miR-34b/c gene rs4938723, EGF gene rs4444903, and KIF1B gene rs17401966 were asso-ciated with PHC risk in the region, and the number of SNPs correlated with clinicopathology in pa-tients with hepatocellular carcinoma.

References

[1]  何凤蝶, 王秋童, 胡亚男, 等. 中国人群肝癌发病危险因素病例对照研究的meta分析[J]. 现代预防医学, 2022, 49(23): 4230-4240.
[2]  Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
[3]  Chen, W., Sun, K., Zheng, R., et al. (2018) Cancer Incidence and Mortality in China, 2014. Chinese Journal of Cancer Research, 30, 1-12.
https://doi.org/10.21147/j.issn.1000-9604.2018.01.01
[4]  Li, Y., Zhang, F. and Yang, D. (2017) Comprehensive Assessment and Meta-Analysis of the Association between Ctnnb1 Polymorphisms and Cancer Risk. Bioscience Re-ports, 37, 432-440.
https://doi.org/10.1042/BSR20171121
[5]  沈影, 夏霁, 韩凤娟. 基因单核苷酸多态性在卵巢癌精准医疗中的应用探析[J]. 中南药学, 2020, 18(4): 627-629.
[6]  周泽文, 张若昕, 魏庆义, 等. 肝细胞癌全基因组关联分析研究进展及展望[J]. 中国癌症防治杂志, 2020, 12(1): 6-13.
[7]  Wang, C., Lu, D., Ling, Q., et al. (2019) Donor Onecarbon Metabolism Gene Single Nucleotide Polymorphisms Predict the Susceptibility of Cancer Re-currence after Liver Transplantation. Gene, 68, 97-101.
https://doi.org/10.1016/j.gene.2018.11.035
[8]  杨怡, 席子涵, 张林颖. 极光激酶B、肿瘤蛋白53在肝细胞癌中的表达及与临床病理特征、预后的关系[J]. 肝脏, 2022, 27(2): 188-192.
[9]  Le, P.H., Kuo, C.J., Hsieh, Y.C., et al. (2019) Ages of Hepatocellular Carcinoma Occurrence and Life Expectancy Are Associated with a UGT2B28 Ge-nomic Variation. BMC Cancer, 19, Article No. 1190.
https://doi.org/10.1186/s12885-019-6409-3
[10]  Huang, Z., Guo, X., Zhang, G., et al. (2019) Correlation between PNPLA3 rs738409 Polymorphism and Hepatocellular Carcinoma: A Meta-Analysis of 10,330 Subjects. The Interna-tional Journal of Biological Markers, 34, 117-122.
https://doi.org/10.1177/1724600818812471
[11]  陆小华, 朱小庆, 袁洪新, 等. APE1基因单核苷酸多态性与肝细胞癌临床表型的相关性研究[J]. 中国当代医药, 2020, 27(13): 13-17.
[12]  Liu, W., Ma, N., Zhao, D., et al. (2019) Correlation between the DEPDC5 rs1012068 Polymorphism and the Risk of HBV-Related Hepatocellular Carci-noma. Clinics and Research in Hepatology and Gastroenterology, 43, 446-450.
https://doi.org/10.1016/j.clinre.2018.12.005
[13]  Xu, B., Zhu, Y., Tang, Y., Zhang, Z., et al. (2018) Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leuke-mia, Colorectal, and Esophageal Cancer. Medical Science Monitor, 24, 7057-7071.
https://doi.org/10.12659/MSM.912534
[14]  Hashemi, M., Moazeni-Roodi, A., Bahari, G., et al. (2019) Associa-tion between miR-34b/c rs4938723 Polymorphism and Risk of Cancer: An Updated Meta-Analysis of 27 Case-Control Studies. Journal of Cellular Biochemistry, 120, 3306-3314.
https://doi.org/10.1002/jcb.27598
[15]  Liu, Q., Yang, G., Song, X.L., et al. (2015) Association between rs4938723 Functional Polymorphism in the Promoter Region of miR-34b/c Gene and Cancer Risk. Clinics and Research in Hepatology and Gastroenterology, 39, 526-533.
https://doi.org/10.1016/j.clinre.2014.10.007
[16]  Zhu, Y., Chen, Z., Jiang, H., et al. (2019) The Genetic Associa-tion between EGF A61G Polymorphism (rs4444903) and Risk of Colorectal Cancer: An Update Meta-Analysis and Trial Sequential Analysis. Medicine, 98, e14007.
https://doi.org/10.1097/MD.0000000000014007
[17]  Laus, A.C., De Paula, F.E., De Lima, M.A., et al. (2019) EGF+61 A>G Polymorphism Is Not Associated with Lung Cancer Risk in the Brazilian Population. Molecular Biology Reports, 46, 2417-2425.
https://doi.org/10.1007/s11033-019-04702-0
[18]  Jiang, G., Yu, K., Shao, L., et al. (2015) Association between Epidermal Growth Factor Gene +61A/G Polymorphism and the Risk of Hepatocellular Carcinoma: A Meta-Analysis Based on 16 Studies. BMC Cancer, 15, Article No. 314.
https://doi.org/10.1186/s12885-015-1318-6
[19]  Li, Y.L., Tian, Z., Zhao, L., et al. (2014) Association between the EGF rs4444903 Polymorphism and Liver Cancer Susceptibility: A Meta-Analysis and Meta-Regression. Genetics and Molecular Research, 13, 8066-8079.
https://doi.org/10.4238/2014.October.7.1
[20]  Wang, J., Zhong, Y. and Meng, G. (2021) EGF rs4444903 Poly-morphism Is Associated with Risk of HCV-Related Cirrhosis and HBV/HCV-Related Hepatocellular Carcinoma. Inter-national Journal of Clinical Oncology Volume, 26, 2053-2064.
https://doi.org/10.1007/s10147-021-01994-w
[21]  Zhang, Y.F., Zeng, X.L., Lu, H.W., et al. (2018) Association between KIF1B (rs17401966) Polymorphism and Hepatocellular Carcinoma Susceptibility: A Meta-Analysis. OncoTar-gets and Therapy, 11, 3225-3235.
https://doi.org/10.2147/OTT.S162205
[22]  Wang, Z.C., Gao, Q., Shi, J.Y., et al. (2013) Genetic Polymorphism of the Kinesin-Like Protein KIF1B Gene and the Risk of Hepatocellular Carcinoma. PLOS ONE, 8, 62571-62573.
https://doi.org/10.1371/journal.pone.0062571
[23]  Luo, Y.Y., Zhang, H.P., Huang, A.L., et al. (2019) Association between KIF1B rs17401966 Genetic Polymorphism and Hepatocellular Carcinoma Susceptibility: An Updated Me-ta-Analysis. BMC Medical Genetics, 20, Article No. 59.
https://doi.org/10.1186/s12881-019-0778-y
[24]  Hsieh, M.C., Hsu, H.T., Hsiao, P.C., et al. (2014) Role of VEGF-C Gene Polymorphisms in Susceptibility to Hepatocellular Carcinoma and Its Pathological Development. Journal of Clinical Laboratory Analysis, 28, 237-244.
https://doi.org/10.1002/jcla.21672
[25]  Zhang, J., Liu, L., Lin, Z., et al. (2019) SNP-SNP and SNP-Environment Interactions of Potentially Functional Hotair SNPs Modify the Risk of Hepatocellular Carcinoma. Molecular Carcino-genesis, 58, 633-642.
https://doi.org/10.1002/mc.22955
[26]  范余娟, 孙丹, 徐红, 等. 子宫内膜癌组织BRCCA1单核苷酸多态性与临床病理因素相关性分析[J]. 中华肿瘤防治杂志, 2015, 22(16): 1283-1286.
[27]  樊菁, 吕勇刚, 赵戈, 等. 甲状腺乳头状癌BRAFV600E、NRAS、TERT基因的突变特征及其与临床病理特征的相关性[J]. 现代肿瘤医学, 2021, 29(5): 769-773.
[28]  Yuan, F., Shi, M., Ji, J., et al. (2014) KRAS and DAXX/ATRX Gene Mutations Are Correlated with the Clinicopathological Features, Advanced Diseases, and Poor Prognosis in Chinese Patients with Pancreatic Neu-roendocrine Tumors. International Journal of Biological Sciences, 10, 957-965.
https://doi.org/10.7150/ijbs.9773
[29]  张冉, 杨洁, 冯恩梓, 等. 甲状腺乳头状癌基因突变与其侵袭性相关性研究[J]. 昆明医科大学学报, 2023, 44(2): 125-132.
[30]  林晓, 董文韬, 赖霄晶, 等. 晚期非小细胞肺癌ctDNA检测及其临床意义的研究[J]. 世界最新医学信息文摘, 2018, 18(99): 18-20.
[31]  贺佳子, 黄清洁, 李莉, 等. 396例非小细胞肺癌EGFR, KRAS, ALK和BRAF基因突变状态及其临床病理特征[J]. 临床与病理杂志, 2020, 40(9): 2252-2258.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133